Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
3.070
+0.040 (1.32%)
Mar 10, 2026, 4:08 PM HKT
15.85% (1Y)
| Market Cap | 7.53B |
| Revenue (ttm) | 763.16M |
| Net Income (ttm) | -175.20M |
| Shares Out | 1.04B |
| EPS (ttm) | -0.17 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.07 (2.24%) |
| Ex-Dividend Date | n/a |
| Volume | 1,021,000 |
| Average Volume | 2,015,950 |
| Open | 3.100 |
| Previous Close | 3.030 |
| Day's Range | 3.050 - 3.110 |
| 52-Week Range | 2.130 - 5.290 |
| Beta | 0.12 |
| RSI | 46.51 |
| Earnings Date | Mar 31, 2026 |